Barrett & Company, Inc. Anixa Biosciences Inc Transaction History
Barrett & Company, Inc.
- $231 Billion
- Q3 2024
A detailed history of Barrett & Company, Inc. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Barrett & Company, Inc. holds 80 shares of ANIX stock, worth $252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 80
-0.0%
Holding current value
$252
Previous $177,000
42.37%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.53MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.39 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.11 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.96 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.67 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.6 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $96.6M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...